Condition: Biliary Tract Neoplasms · Sponsor: UNICANCER
The object of this trial is to evaluate whether the introduction of a targeted therapy after 4 cycles of the current standard-of-care treatment for advanced biliary cancer is superior to continuing with the standard treatment. The trial is composed of two phases: (i) An initial screening phase to identify a suitable patient population, during which a molecular profile of the patient's tumour will be obtained, and (ii) a randomised comparative trial in which patients with disease control after 4 cycles of standard treatment, and whose tumour harbours a targetable molecular alteration, will be randomised (2:1) to receive either a matched targeted therapy or to continue with the standard treatment.
This description comes directly from the study's public registry record.
Marta Jimenez · +33 (0) 1 44 23 55 58 · m-jimenez@unicancer.fr
Always discuss trial participation with your own doctor first.
| Cliniques universitaires de Bruxelles - Hôpital Erasme ULB | Brussels, Belgium | Not Yet Recruiting |
| Cliniques universitaires Saint-Luc | Brussels, Belgium | Not Yet Recruiting |
| Universitair Ziekenhuis Antwerpen (UZA) | Edegem, Belgium | Not Yet Recruiting |
| Universitair Ziekenhuis Leuven | Leuven, Belgium | Not Yet Recruiting |
| CHU Amiens Picardie | Amiens, France | Recruiting |
| CHU d'Angers | Angers, France | Recruiting |
| Institut de cancerologie de l'Ouest - Angers | Angers, France | Recruiting |
| Institut du Cancer Avignon Provence | Avignon, France | Recruiting |
| CHU de Besançon | Besançon, France | Recruiting |
| CHU de Bordeaux - Hôpital Haut-Leveque | Bordeaux, France | Not Yet Recruiting |
| Centre François Baclesse | Caen, France | Recruiting |
| Centre Jean Perrin | Clermont-Ferrand, France | Recruiting |
+ 57 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05615818